Challenges to drug discovery for celiac disease and approaches to overcome them
| Autor: | Begoña Álvarez-Cuenllas, Luis Vaquero, Santiago Vivas, Laura Rodríguez-Martín, Francisco Leon, David Bernardo |
|---|---|
| Přispěvatelé: | Instituto de Salud Carlos III, European Commission |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Tissue transglutaminase Disease Intestinal permeability Immunomodulation Diet Gluten-Free 03 medical and health sciences 0302 clinical medicine Drug Development Drug Discovery medicine Animals Humans Effective treatment Celiac disease Intensive care medicine Complete response 030304 developmental biology chemistry.chemical_classification 0303 health sciences biology Drug discovery business.industry nutritional and metabolic diseases Proteases medicine.disease Gluten digestive system diseases chemistry 030220 oncology & carcinogenesis Quality of Life biology.protein Gluten tolerance Gluten free business |
| Zdroj: | Digital.CSIC. Repositorio Institucional del CSIC instname |
| Popis: | [Introduction] The only available effective treatment for celiac disease (CD) is strict and long-term compliance with a gluten-free diet. Dietary gluten restriction must be strict and long term, but is difficult to achieve in many cases and alternative dietary strategies have been investigated in the past few years. [Areas covered] This review highlights the progress that has been made in the development of new therapeutics for CD. Detailed information is provided on the targets of drugs for CD as their related mechanisms of action. The therapies are classified in five mechanisms: modification of gluten, intraluminal therapies, immunomodulation, intestinal permeability and modulation of adaptative response. The actual development phase and future approach are also described and discussed. [Expert opinion] There are several limitations in each of the treatment targets related either through complications or the lack of complete response to a normal gluten containing diet. It is clear that the most desired therapy for celiac patients would induce gluten tolerance and progress has been made as per the treatments described herein. Therefore, it is shortly expected that curative or complimentary tools to a gluten free diet will be available that will improve the quality of life of CD sufferers. This study was funded in part by a grant from the Instituto de Salud Carlos III, Fondo de Investigación Sanitaria, (Ref PI13/01133 and PI16/01574), co-funded by FEDER (European Regional Development Fund). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|